Vanda Pharmaceuticals (VNDA) Total Liabilities (2016 - 2025)
Historic Total Liabilities for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q4 2025 value amounting to $161.8 million.
- Vanda Pharmaceuticals' Total Liabilities rose 3748.49% to $161.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $161.8 million, marking a year-over-year increase of 3748.49%. This contributed to the annual value of $161.8 million for FY2025, which is 3748.49% up from last year.
- As of Q4 2025, Vanda Pharmaceuticals' Total Liabilities stood at $161.8 million, which was up 3748.49% from $135.1 million recorded in Q3 2025.
- In the past 5 years, Vanda Pharmaceuticals' Total Liabilities registered a high of $161.8 million during Q4 2025, and its lowest value of $75.6 million during Q1 2021.
- In the last 5 years, Vanda Pharmaceuticals' Total Liabilities had a median value of $105.0 million in 2022 and averaged $108.0 million.
- Per our database at Business Quant, Vanda Pharmaceuticals' Total Liabilities crashed by 718.55% in 2023 and then surged by 3748.49% in 2025.
- Quarter analysis of 5 years shows Vanda Pharmaceuticals' Total Liabilities stood at $88.9 million in 2021, then rose by 20.46% to $107.0 million in 2022, then dropped by 3.29% to $103.5 million in 2023, then rose by 13.65% to $117.7 million in 2024, then soared by 37.48% to $161.8 million in 2025.
- Its Total Liabilities was $161.8 million in Q4 2025, compared to $135.1 million in Q3 2025 and $138.4 million in Q2 2025.